Other study examining the association between GLP-1 RAs and cholangiocarcinoma did not find a significant increase in risk with their use, although 26 cases were reported, failing to establish a statistically significant association between GLP-1 RA use and increased risk (Ueda et al., 2021). Here, GLP1R is linked to cholangiocarcinoma.